02096.HK
Simcere Pharmaceutical Group Limited
HKSE · Healthcare · Biotechnology · CN
HKD 10.14
−2.31%Leverage
- Debt / equity
- 0.26x
- Net debt / equity
- -0.07x
- Debt / assets
- 0.16x
- Debt / EBITDA
- 1.19x
- Net debt / EBITDA
- -0.32x
Liquidity & coverage
- Current ratio
- 1.90x
- Quick ratio
- 1.74x
- Cash ratio
- 1.03x
- Interest coverage
- 19.09x
- EBITDA / interest
- 21.67x
- Working capital
- HKD 4.2B
Cash & dividend
- FCF / debt
- 0.90x
- Cash flow / debt
- 1.14x
- Dividend per share
- HKD 0.21
- Dividend yield
- 2.0%
- Dividend growth 1y
- +18.4%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026